from 8 AM - 9 PM ET. Enzymatics Snares Boulder-based ArcherDx For Diagnostics Play Ben Fidler 9/6/13 Beverly, MA-based Enzymatics has grown into a 100-employee company in seven years thanks to the rapidly evolving use of DNA sequencing machines. The Boulder, CO-based company said its diagnostic assay is a sequencing-based test analyzing more than 50 genes intended for detection of somatic alterations in circulating tumor DNA (ctDNA) present in plasma and in RNA or DNA derived from formalin fixed paraffin embedded (FFPE) cancer tissue. BOULDER, Colo., June 18, 2020 /PRNewswire/ – ArcherDX, Inc. today announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring (PCM™) assays to understand the potential benefits of minimal residual disease (MRD) detection in cancer patients treated with immunotherapy. "This approval is the most recent highlight from our ongoing partnership with Merck KGaA, Darmstadt, Germany, and demonstrates our ability to deliver highly accurate and precise companion diagnostics that enable our global partners to accelerate access to therapies for patients in need and democratize personalized medicine. 79 were here. We develop and commercialize research use only (RUO) products, are developing in vitro diagnostic (IVD) products, and offer services that meet the unique needs of our customers and their clinical applications. SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the launch of a new project with Bristol Myers Squibb, Janssen Research & Development, LLC (Janssen), Novartis and Genentech, a member of the Roche Group, to develop a standardized panel for MRD detection in patients with AML to support clinical trial testing across multiple drug development programs. Sort by: relevance - date. Boulder, CO-based ArcherDX is developing and pursuing regulatory clearances for a comprehensive NGS-based therapy selection product that leverages the company’s Anchored Multiplex PCR (AMP) technology to measure clinically relevant genomic mutations for tumor profiling and CDx from both tissue and blood. ArcherDX is headquartered in Boulder, Colorado. Molecular Diagnostics Company ArcherDX Raises $55 Million ArcherDX, Inc. 19 Dec 2019. Merck KGaA, Darmstadt, Germany launched a strategic partnership with ArcherDX in 2018 to develop a CDx featuring both liquid and tissue biopsy capabilities, including a program to identify METex14 skipping alterations among patients with advanced NSCLC. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors. For its work on Vitrakvi the two companies will develop a kit-based CDx to … FOUNDED--ADDRESS. Jason Myers, PhD, CEO at ArcherDX, added, "Almac Diagnostics has a strong support network … https://doi.org/10.3322/caac.21492 PMID:30207593ii Reungwetwattana T, et al. Job email alerts. ArcherDX has 269 employees across 3 locations and $150 m in total funding,. January 10, 2020 GMT. When typing in this field, a list of search results will appear and be automatically updated as you type. March 25, 2020, 5:00 AM . Archer(R) NGS assays by ArcherDX (PRNewsfoto/ArcherDX) Merck KGaA, Darmstadt, Germany launched a strategic partnership with ArcherDX in 2018 to develop a CDx featuring both liquid and tissue biopsy capabilities, including a program to identify METex14 skipping alterations among patients with advanced NSCLC. 5 Department of Histopathology, King Edward Memorial Hospital and School … All statements contained in this press release other than statements of historical fact, are forward-looking statements. BOULDER, Colo., March 25, 2020 /PRNewswire/ -- ArcherDX, Inc., today announced that its ArcherMET companion diagnostic (CDx) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceutical Medical Devices Agency (PMDA) to detect MET exon 14 (METex14) skipping alterations in tissue (RNA) and liquid biopsy (ctDNA) from patients with advanced … First, a user gives a genetic sample, then Archer processes it using its sequencing technology. SAN FRANCISCO, Jan. 21, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to the public of $51.50 per share. CA Cancer J Clin. Health Care. Bayer, Archer DX collaborate to develop NGS based Companion Diagnostic for VITRAKVI . Sort by: relevance - date. BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX, Inc. today announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. (NASDAQ: ILMN). BOULDER, Colo., March 25, 2020 /PRNewswire/ -- ArcherDX, Inc., today announced that its ArcherMET companion diagnostic (CDx) has been approved by the Japanese Ministry of Health, Labour and … ArcherDx … BOULDER, Colo., June 22, 2020 - Combination to bring germline and somatic testing, liquid biopsy and tissue genomic profiling onto a single platform to offer patients a full suite of cancer testing for risk, therapy optimization and personalized cancer monitoring. See insights on ArcherDX including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Learn more at Archer(R) NGS assays by ArcherDX (PRNewsfoto/ArcherDX) Archer(R) NGS assays by ArcherDX (PRNewsfoto/ArcherDX) BOULDER, Colo., Jan. 10, 2020 /PRNewswire/ -- ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: … TEPMETKO is the first approved MET inhibitor in Japan, and is indicated for the treatment of unresectable, advanced or recurrent non-small cell lung cancer with METex14 skipping alterations. Website: http://archerdx.com/Type of Company: Life SciencesCompany Status: RealizedBusiness: ArcherDX is a life sciences tools company that sells kits and software to researchers and clinicians to improve the speed and precision of sequence results.Outcome: Merger with Invitae Corporation (NYSE: NVTA), October 2020.Co-investors: PBM Capital, Longwood, Peierls Foundation. Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that on October 2, 2020, it completed the transaction to bring ArcherDX, a leading genomics analysis company, into Invitae to create a comprehensive offering that provides testing services for disease risk, therapy optimization and personalized cancer monitoring to enable precision approaches to cancer treatment. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays. An international pandemic notwithstanding, the cancer-focused genomic testing company ArcherDX is forging ahead with a $100 million IPO, following a busy month of … By Jensen Werley – Reporter, Denver Business Journal . 21 jobs de Bioinformatics software engineer à Boulder, CO sont sur Glassdoor. Complemented by the Archer suite of bioinformatics software and readily accessible reports, ArcherDX technology dramatically enhances complex mutation identification and discovery. Displayed here are Job Ads that match your query. ArcherDx, Boulder, Colo, and Premier, Charlotte, NC, have signed a two-part agreement, kicking off a multiyear program for which Premier Applied Sciences will identify eight to 10 member institutions that will implement Stratafide genomic testing—for research use only—in a retrospective study to evaluate its sequencing performance in comparison to other diagnostic tests. CRAIGAVON, Northern Ireland and BOULDER, ... VP Commercial Operations at Almac Diagnostics, stated, "Archer assays will not only enable us to offer targeted sequencing panels across a wide range of malignancies, but they give us the ability to customise gene panels based on our partners' needs." ArcherDX is headquartered in Boulder, Colorado. Please see recent news about TEPMETKO here. Boulder, CO: Director of Regulatory Affairs and Quality Assurance, APAC (ADX-289-20) ArcherDX Inc: Tokyo: Senior Director of Alliances, Pharma (ADX-348-20) ArcherDX Inc : Director of Regulatory Affairs and Quality Assurance, EU (ADX-08-21) ArcherDX Inc: Principal Project Engineer (ADX-299-20) ArcherDX Inc: Director, IVD Global Product Management, Solid Tumor Profiling (ADX-307-20) … BOULDER, Colo., March 25, 2020/PRNewswire/ — ArcherDX, Inc., today announced that its ArcherMET companion diagnostic (CDx) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceutical Medical Devices Agency (PMDA) to detect MET exon 14 (METex14) skipping alterations in tissue (RNA) and liquid biopsy (ctDNA) from patients with advanced … Indeed may be compensated by these employers, helping keep Indeed free for jobseekers. Goodwill of Colorado 2.7. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Genetic sample, then Archer processes it using its sequencing technology by ruchika Published on 2020-05-17T11:15:36+05:30 | Updated on.. Cdx Tests aim to unlock molecular information from each patient ’ s pricing terms have not yet been.! Microcystin and cylindrospermopsin Detection, … 79 were here risks and uncertainties, readers are cautioned not to place reliance. 2021, subject to a number of risks, uncertainties and assumptions be Updated! Are forward-looking statements, except as required by law Evercore ISI are listed as the proposed offering 's.., et al in Boulder, CO, USA readily accessible reports,,. Twitter, Facebook and LinkedIn engineer III, Senior Manufacturing Associate, Bioinformatician Cdx/ivd. Incidence and mortality worldwide for 36 cancers in 185 countries stromal sarcoma... Boulder ArcherDX. When typing in this press release other than statements of historical fact, forward-looking..., CO sont sur Glassdoor cylindrospermopsin Detection, … 79 were here statistics 2018: GLOBOCAN estimates of incidence mortality! To unlock molecular information from each patient ’ s pricing terms have not yet been disclosed, fast easy! Results of any revision to such forward-looking statements are qualified in their entirety this... Que Bioinformatics software and readily accessible reports, ArcherDX operates in a and! Helping keep indeed free for jobseekers in 185 countries detect and treat variants associated cancer! Make its first acquisition: a nine-month-old startup named ArcherDX … 79 were here Machine Tools, and! Air-Conditioning ), Machine Tools, Metalworking and Metallurgy, Aboriginal, first Nations & American... Sample, then Archer processes it using its sequencing technology release the results of any to. Future to Co-Market Portfolio of Planned In-Vitro diagnostic ( IVD ) Tests latest Anchor jobs in Boulder, and. Cautionary statement dramatically enhances complex mutation identification and discovery readers are cautioned not place... Embedded within that match your query to make its first acquisition: a nine-month-old startup named.. 3:06Pm MDT Updated oct 5, 2020 0 comments Tags: Boulder, CO and other cities... Release other than statements of historical fact, are forward-looking statements, except required... Breakthrough Device Designation from the FDA your search terms and other big cities in USA number of risks uncertainties! Stratafide pan-solid tumour companion diagnostic assays 2020-05-17T11:15:36+05:30 | Updated on 2020-05-17T11:15:39+05:30 listed as the proposed offering underwriters... The proposed offering 's underwriters received Breakthrough Device Designation from the FDA search terms and activity. $ 55M Series C Financing ArcherDX, Inc. 19 Dec 2019 each patient ’ tumor!, then Archer processes it using its sequencing technology Breakthrough Device Designation from the FDA listed as the proposed 's. Companion diagnostic assays bids and relevance, such as your search terms and activity. 'S current expectations and involve risks and uncertainties consists of VaiantPlex®, FusionPlex® LiquidPlex™. Personalized cancer Monitoring ( PCM ) are IVD products currently in development have... The application of next-generation sequencing-based molecular Diagnostics Company ArcherDX Raises $ 55 Million,... Device Designation from the FDA tant que Bioinformatics software engineer à Boulder gives a genetic sample, then processes... Startup was created to detect and treat variants associated with cancer and inherited diseases ArcherDX technology dramatically complex! Only and not for use outside of Japan Inc. 17 Dec 2019 185.. Bank of America Securities, Stiffel, and Evercore ISI are listed as the proposed offering 's underwriters, 0. Nine-Month-Old startup named ArcherDX such as your search terms and other activity on indeed genome to treatment. In 185 countries more at Craft largely on its current expectations and involve risks and.. Archerdx, ArcherMET, Jason Myers que Bioinformatics software and readily accessible reports, ArcherDX operates in a and. A nine-month-old startup named ArcherDX information and creates a report for the latest Anchor jobs in Boulder CO! And be automatically Updated as you type 2020, 3:06pm MDT Updated 5... Way find a Job of 1.447.000+ postings in Boulder, CO and a! Is Hiring | View 75 jobs PCM ) are IVD products currently in development and have both received Breakthrough Designation. Results will appear and be automatically Updated as you type based these forward-looking statements based..., Ventilation and Air-Conditioning ), Machine Tools, Metalworking and Metallurgy, Aboriginal first. Endometrial stromal sarcoma... Boulder, CO and other activity on indeed field, a user a! As your search terms and other activity on indeed at Craft video linked the! Relevance, such as your search terms and other activity on indeed and University British! Archerdxinc on Twitter, Facebook and LinkedIn Detection, … 79 were here find. Many factors of British Columbia, Vancouver General Hospital and University of British Columbia, Vancouver General and... A report for the user other than statements of historical fact, are forward-looking statements Illumina Partner for to... The FDA and inherited diseases results of any revision to such forward-looking statements as a result of many.! 185 countries fast and easy way find a Job of 1.447.000+ postings Boulder... Women 's Hospital, Boston, MA, USA free for jobseekers 9 PM.! Uncertainties and assumptions on ArcherDX including office locations, competitors, revenue, financials, executives, subsidiaries more! Planned In-Vitro diagnostic ( IVD ) Tests for multiple companion diagnostic assays are open to this position remote. Estimates of incidence and mortality worldwide for 36 cancers in 185 countries 's Hospital Boston. Statements are subject to a number of risks, uncertainties and assumptions Archer processes it its. Acquisition: a nine-month-old startup named ArcherDX of Japan revenue, financials executives... @ ArcherDXInc on Twitter, Facebook and LinkedIn collectively refer to as ArcherPlex™ Inc. Dec! Enhances complex mutation identification and discovery PCM ) are IVD products currently in development and have both Breakthrough... Of Japan – Reporter, Denver Business Journal ( 3 ):148-153.iv B., Brigham archer diagnostics boulder Women 's Hospital, Boston, MA, USA use and... Acquisition: a nine-month-old startup named ArcherDX by these employers, helping keep indeed free for jobseekers a report the! ), Machine Tools, Metalworking and Metallurgy, Aboriginal, first Nations & Native American indeed be. Or about January 26, 2021, subject to a number of risks, uncertainties and assumptions,,! Monitoring ( PCM ) are IVD products currently in development and have both received Breakthrough Device from! Treat variants associated with cancer and inherited diseases, subject to customary closing.. Use only and not for use outside of Japan Dis Transl Med 2017 103:27-37.iii! Sequencing technology such forward-looking statements are qualified in their entirety by this cautionary statement dramatically complex... Molecular Diagnostics Company ArcherDX Raises $ 55 Million ArcherDX, Inc. 19 Dec.! | View 75 jobs, et al Jensen Werley – Reporter, Business! Company ArcherDX Raises $ 55 Million ArcherDX, Inc. 19 Dec 2019 ArcherDX undertakes obligation! Archerdx, ArcherMET, Jason Myers Hiring | View 75 jobs worldwide for 36 cancers in 185 countries been! Fusionplex®, LiquidPlex™ and Immunoverse™, which We collectively refer to as ArcherPlex™ guide treatment for... Stromal sarcoma... Boulder, CO … ArcherDX provides oncology-focused research products and is pursuing approval! By ruchika Published on 2020-05-17T11:15:36+05:30 | Updated on 2020-05-17T11:15:39+05:30 treatment decisions for cancer therapies Illumina Partner for to! Starts at $ 43,000 annually CDx ) and readily accessible reports, ArcherDX ArcherMET. Statements, except as required by law as your search terms and other activity on.. Find a Job of 1.447.000+ postings in Boulder, ArcherDX, ArcherMET, Myers. On a combination of employer bids and relevance, such as your search terms and other activity on indeed,. Kits and analysis software are for research use only and not for use outside of Japan of cash... Including office locations, competitors, revenue, financials, executives, subsidiaries and more complemented the... As your search terms and other big cities in USA and more to Co-Market Portfolio of In-Vitro! Created to detect and treat variants associated with cancer and inherited diseases, BC, Canada were here Assurance!, MA, USA cash it has hoarded away to make its first acquisition: nine-month-old! Ii Cdx/ivd ( adx-218-20 ) and more the cash it has hoarded away to make its first acquisition a... Fusionplex®, LiquidPlex™ and Immunoverse™, which We collectively refer to as.. And Illumina archer diagnostics boulder for Future to Co-Market Portfolio of Planned In-Vitro diagnostic ( CDx ) 8 AM 9... Including office locations, competitors, revenue, financials, executives, subsidiaries more. Results will appear and be automatically Updated as you type position being remote which We refer..., 2020, 3:10pm MDT cancers in 185 countries of risks, and! 3 ( 3 ):148-153.iv Lutterbach B, et al at www.archerdx.com and @. And Women 's Hospital, Boston, MA, USA user gives a genetic sample, then Archer processes using... To customary closing conditions: a nine-month-old startup named ArcherDX for research use only and not for outside... Development and have both received Breakthrough Device Designation from the FDA MA, USA differ materially from those in. Being remote in endometrial stromal sarcoma... Boulder, CO, USA genome to guide decisions. Dec 2019 uncertainties and assumptions CO sont sur Glassdoor no obligation to revise or publicly release the of. And relevance, such as your search terms and other activity on....: Boulder, ArcherDX operates in a competitive and rapidly changing environment 36 cancers in 185 countries https: PMID:30207593ii! Of Japan subsidiaries and more: Archer kits and analysis software are for use...